EE200000627A - Inimese BMP-7 promootori DNA, selle valmistamismeetod, ekspressioonivektor ning meetod luuga seotudja neeruhaiguste raviks ettenähtud aine uurimiseks - Google Patents

Inimese BMP-7 promootori DNA, selle valmistamismeetod, ekspressioonivektor ning meetod luuga seotudja neeruhaiguste raviks ettenähtud aine uurimiseks

Info

Publication number
EE200000627A
EE200000627A EEP200000627A EEP200000627A EE200000627A EE 200000627 A EE200000627 A EE 200000627A EE P200000627 A EEP200000627 A EE P200000627A EE P200000627 A EEP200000627 A EE P200000627A EE 200000627 A EE200000627 A EE 200000627A
Authority
EE
Estonia
Prior art keywords
investigation
bone
expression vector
kidney disease
promoter dna
Prior art date
Application number
EEP200000627A
Other languages
English (en)
Estonian (et)
Inventor
Kawai Shinji
Sugiura Takeyuki
Original Assignee
Hoechst Marion Roussel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel filed Critical Hoechst Marion Roussel
Publication of EE200000627A publication Critical patent/EE200000627A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/51Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200000627A 1998-04-30 1999-04-22 Inimese BMP-7 promootori DNA, selle valmistamismeetod, ekspressioonivektor ning meetod luuga seotudja neeruhaiguste raviks ettenähtud aine uurimiseks EE200000627A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10120174A JPH11313675A (ja) 1998-04-30 1998-04-30 ヒトbmp−7プロモーターおよびこれを用いた骨関連物質の探索法
PCT/IB1999/000733 WO1999057293A1 (fr) 1998-04-30 1999-04-22 Promoteur humain bmp-7 et procédé permettant d'explorer une substance de type osseux

Publications (1)

Publication Number Publication Date
EE200000627A true EE200000627A (et) 2002-02-15

Family

ID=14779761

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000627A EE200000627A (et) 1998-04-30 1999-04-22 Inimese BMP-7 promootori DNA, selle valmistamismeetod, ekspressioonivektor ning meetod luuga seotudja neeruhaiguste raviks ettenähtud aine uurimiseks

Country Status (26)

Country Link
US (2) US6534268B1 (fr)
EP (1) EP1076713A1 (fr)
JP (1) JPH11313675A (fr)
KR (1) KR20010071193A (fr)
CN (1) CN1170941C (fr)
AP (1) AP1329A (fr)
AU (1) AU769124B2 (fr)
BG (1) BG64780B1 (fr)
BR (1) BR9910585A (fr)
CA (1) CA2326957A1 (fr)
EA (1) EA004509B1 (fr)
EE (1) EE200000627A (fr)
GE (1) GEP20033056B (fr)
HR (1) HRP20000736A2 (fr)
HU (1) HUP0102329A3 (fr)
ID (1) ID26704A (fr)
IL (1) IL139100A0 (fr)
NO (1) NO20005433D0 (fr)
NZ (1) NZ507625A (fr)
PL (1) PL343817A1 (fr)
SK (1) SK16082000A3 (fr)
TR (1) TR200003182T2 (fr)
UA (1) UA72212C2 (fr)
WO (1) WO1999057293A1 (fr)
YU (1) YU64900A (fr)
ZA (1) ZA200006080B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004060346A2 (fr) 2002-12-30 2004-07-22 Angiotech International Ag Liberation de medicaments a partir d'une composition polymere a gelification rapide
US20070015701A1 (en) * 2005-06-01 2007-01-18 Samuel Zalipsky Macromolecular conjugates of bone morphogenetic protein-7
PT2078073E (pt) * 2006-10-12 2013-11-11 Ethicon Inc Células derivadas do rim e métodos de utilização na reparação e regeneração de tecidos
CN101868245B (zh) * 2008-05-16 2013-10-23 全南大学校产学协力团 含有用于刺激成骨细胞分化的骨形成肽1(bfp1)的合成肽及含有上述合成肽的药物组合物
EP2579904A4 (fr) 2010-06-09 2015-12-02 Semprus Biosciences Corp Compositions à greffons antisalissure, antimicrobiennes, anti-thrombotiques
CN103037913B (zh) 2010-06-09 2016-03-09 森普鲁斯生物科学公司 防污、抗微生物、抗血栓形成的接出型组合物
US8632838B2 (en) 2010-06-09 2014-01-21 Semprus Biosciences Corporation Articles having non-fouling surfaces and processes for preparing the same including pretreatment of articles
EP3187197B1 (fr) 2010-08-18 2020-01-01 Emory University Composés et compositions pour ossification et procédés associés
EP2678052B1 (fr) 2011-02-24 2018-09-26 Emory University Compositions antagonistes de jab1 pour ossification et procédés associés à celles-ci
CA2827392A1 (fr) 2011-02-24 2012-08-30 Emory University Compositions antagonistes de noggine pour ossification et procedes associes a celles-ci
WO2013090780A1 (fr) 2011-12-14 2013-06-20 Semprus Biosciences Corp. Lentilles de contact à surface modifiée
JP2015502437A (ja) 2011-12-14 2015-01-22 センプラス・バイオサイエンシーズ・コーポレイションSemprus Biosciences Corp. ランタニド又は遷移金属酸化剤を用いて改質したシリコーンヒドロゲルコンタクトレンズ
CA2859047C (fr) 2011-12-14 2017-03-21 Semprus Biosciences Corp. Processus redox destines a la modification de lentilles de contact
WO2013090801A1 (fr) 2011-12-14 2013-06-20 Semprus Biosciences Corp. Processus uv à stades multiples destinés à créer des lentilles de contact à surface modifiée
CA2859195C (fr) 2011-12-14 2016-09-27 Semprus Biosciences Corp. Processus d'impregnation destine a la modification de la surface de lentilles de contact
WO2019005563A1 (fr) * 2017-06-27 2019-01-03 St. Jude Children's Research Hospital Méthodes liées à l'activation de la voie de signalisation des protéines morphogénétiques osseuses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990011366A1 (fr) 1989-03-28 1990-10-04 Genetics Institute, Inc. Compositions osteoinductrices
US5266683A (en) 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
US5650276A (en) * 1991-03-11 1997-07-22 Creative Biomolecules, Inc. Morphogenic protein screening method
AU2407192A (en) * 1991-08-01 1993-03-02 Pharmaceutical Discovery Corporation Characterization of specific drug receptors with fluorescent ligands
AU703445B2 (en) * 1994-06-07 1999-03-25 Stryker Corporation Methods and compositions for modulating morphogenic protein expression
US6083690A (en) 1995-06-02 2000-07-04 Osteoscreen, Inc. Methods and compositions for identifying osteogenic agents
AU5558498A (en) 1996-11-22 1998-06-22 Akzo Nobel N.V. Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis
US5863790A (en) 1997-05-14 1999-01-26 Minnesota Mining And Manfacturing Company Biological sterility indicator
AU745514B2 (en) * 1997-05-29 2002-03-21 Curis, Inc. Modulators of morphogen expression and methods of identifying the same

Also Published As

Publication number Publication date
BR9910585A (pt) 2001-01-09
AU3163499A (en) 1999-11-23
AP1329A (en) 2004-11-22
BG104883A (en) 2001-05-31
BG64780B1 (bg) 2006-03-31
JPH11313675A (ja) 1999-11-16
HUP0102329A2 (hu) 2001-10-28
UA72212C2 (en) 2005-02-15
ID26704A (id) 2001-02-01
PL343817A1 (en) 2001-09-10
TR200003182T2 (tr) 2001-02-21
IL139100A0 (en) 2001-11-25
EA200001130A1 (ru) 2001-04-23
US20030040007A1 (en) 2003-02-27
HRP20000736A2 (en) 2001-10-31
SK16082000A3 (sk) 2001-05-10
HUP0102329A3 (en) 2006-03-28
EP1076713A1 (fr) 2001-02-21
NZ507625A (en) 2003-12-19
AU769124B2 (en) 2004-01-15
CN1170941C (zh) 2004-10-13
US6534268B1 (en) 2003-03-18
NO20005433L (no) 2000-10-27
ZA200006080B (en) 2001-10-29
EA004509B1 (ru) 2004-04-29
NO20005433D0 (no) 2000-10-27
AP2000001982A0 (en) 2000-12-31
CA2326957A1 (fr) 1999-11-11
KR20010071193A (ko) 2001-07-28
GEP20033056B (en) 2003-08-25
YU64900A (sh) 2003-10-31
CN1307643A (zh) 2001-08-08
WO1999057293A1 (fr) 1999-11-11

Similar Documents

Publication Publication Date Title
EE200000627A (et) Inimese BMP-7 promootori DNA, selle valmistamismeetod, ekspressioonivektor ning meetod luuga seotudja neeruhaiguste raviks ettenähtud aine uurimiseks
AU2003284891A1 (en) A34 and a33-like 3 dna, proteins, antibodies thereto and methods of treatment using same
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
AU2002216273A1 (en) Proteins, genes and their use for diagnosis and treatment of kidney response
DE69728408D1 (de) Nichtinvasive abbildung von biologischem gewebe
WO2003055443A3 (fr) Proteines morphogeniques osseuses (bmp), recepteurs desdites proteines et proteines de liaison de ces proteines, et leur utilisation pour le diagnostic et le traitement du glaucome
DE69830087D1 (de) Gerät zur therapeutischen Kauterisation von vorbestimmten Volumen biologischen Gewebes
WO2001066596A3 (fr) Gene humain fgf-23 et produits d'expression genique
SG121733A1 (en) Nucleic acid molecules polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
ZA965565B (en) Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits.
WO2002022871A3 (fr) Gene humain de l'osteoporose
WO2002046767A3 (fr) Molecules d'acide nucleique, polypeptides et utilisations associees, parmi lesquelles diagnostic et traitement de la maladie d'alzheimer
DE69831223D1 (de) Gefriergetrocknete zusammensetzung des menschlichen,morphogenen knochenproteins mp52
AU2001233954A1 (en) Proteins, genes and their use for diagnosis and treatment of schizophrenia
EE200000631A (et) Inimese BMP-4 promootori DNA, selle valmistamismeetod, ekspressioonivektor ning meetod luuga seotudaine uurimiseks
WO2001083524A3 (fr) Proteines du metabolisme de l'arn
AU2001240820A1 (en) Proteins, genes and their use for diagnosis and treatment of vascular dementia
EA200100544A1 (ru) Способ экспресс-диагностики физиологического состояния биологического объекта и устройство для его осуществления
WO2001032693A3 (fr) Proteine mtr1 apparentee aux proteines trp et sequence adn codant pour celle-ci
WO2002016587A3 (fr) Proteines associees aux microtubules et tubulines
WO2002034282A3 (fr) Protéine mammalienne secrétée convenant au traitement et au diagnostic de cancers
AU2002222308A1 (en) Proteins, genes and their use for diagnosis and treatment of vascular response
WO2002004510A3 (fr) Proteines liant le nucleotide guanine
DE69836971D1 (de) Methode und apparat zur vorhersage von funktionellen proteindomänen, methode zur verbesserung der proteinfunktion, sowie funktionell verbessertes protein
ATA159597A (de) Präparat zur behandlung von blutgerinnungsstörungen

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner